Trial Details

COMPLETED
Basic Information
Clinical ID c4577
Identifier NCT00299013
Trial Title Study of COLAL-PRED® in the Treatment of Moderate Acute Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Ulcerative Colitis
Interventions DRUG: COLAL-PRED®|DRUG: Prednisolone
Participant Information
Sponsor Alizyme
City New South Wales
Country/Region Australia
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2006-03
Primary Completion Date 2008-04
Completion Date 2008-04